UK markets closed

Kala Pharmaceuticals, Inc. (KALA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
6.30+0.11 (+1.78%)
At close: 04:00PM EDT
6.75 +0.45 (+7.14%)
After hours: 06:10PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
50,895
70,495
92,136
77,264
Other short-term investments
-
-
0
76,276
Total cash
50,895
70,495
92,136
153,540
Net receivables
117
195
15,345
9,604
Inventory
-
0
8,639
5,229
Other current assets
1,184
1,355
3,183
2,150
Total current assets
52,870
85,942
124,366
171,379
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,888
1,640
6,882
34,443
Accumulated depreciation
-1,110
-1,224
-2,861
-3,424
Net property, plant and equipment
2,778
416
4,021
31,019
Other long-term assets
301
462
11,040
19,208
Total non-current assets
3,079
878
15,061
50,227
Total assets
55,949
86,820
139,427
221,606
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
5,000
-
-
Accounts payable
919
2,832
4,899
1,724
Accrued liabilities
3,402
5,576
14,662
9,295
Deferred revenues
1,075
4,189
0
-
Other current liabilities
-
4,146
3,817
-
Total current liabilities
8,346
25,685
37,422
22,225
Non-current liabilities
Long-term debt
34,190
37,937
78,929
72,243
Other long-term liabilities
4,110
4,224
4,841
-
Total non-current liabilities
40,099
42,161
85,201
99,386
Total liabilities
48,445
67,846
122,623
121,611
Stockholders' equity
Common stock
3
2
1
59
Retained earnings
-629,409
-587,210
-542,388
-399,783
Accumulated other comprehensive income
0
0
0
4
Total stockholders' equity
7,504
18,974
16,804
99,995
Total liabilities and stockholders' equity
55,949
86,820
139,427
221,606